CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 260 filers reported holding CONMED CORP in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,691,089 | +4.1% | 16,767 | +40.3% | 0.00% | -33.3% |
Q2 2023 | $1,624,291 | +21.9% | 11,952 | -6.8% | 0.00% | 0.0% |
Q1 2023 | $1,332,130 | +39.9% | 12,823 | +19.3% | 0.00% | +50.0% |
Q4 2022 | $952,382 | +4.3% | 10,751 | -5.7% | 0.00% | 0.0% |
Q3 2022 | $913,000 | -0.7% | 11,396 | +18.8% | 0.00% | 0.0% |
Q2 2022 | $919,000 | -49.8% | 9,593 | -6.5% | 0.00% | -50.0% |
Q1 2022 | $1,829,000 | +30.6% | 10,257 | +3.9% | 0.00% | +33.3% |
Q4 2021 | $1,400,000 | +31.6% | 9,874 | +21.5% | 0.00% | +50.0% |
Q3 2021 | $1,064,000 | +8.1% | 8,130 | +13.6% | 0.00% | 0.0% |
Q2 2021 | $984,000 | +8.4% | 7,157 | +3.0% | 0.00% | 0.0% |
Q1 2021 | $908,000 | +42.1% | 6,948 | +21.7% | 0.00% | 0.0% |
Q4 2020 | $639,000 | -17.5% | 5,707 | -41.9% | 0.00% | 0.0% |
Q3 2020 | $775,000 | +37.9% | 9,829 | +26.3% | 0.00% | 0.0% |
Q2 2020 | $562,000 | +23.8% | 7,784 | -1.8% | 0.00% | 0.0% |
Q1 2020 | $454,000 | – | 7,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 41,984 | $4,234,086 | 3.80% |
Ranger Investment Management | 334,874 | $33,772,043 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 114,000 | $11,496,900 | 2.24% |
EARNEST PARTNERS LLC | 2,265,092 | $228,434,528 | 1.32% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 144,376 | $14,560,320 | 1.01% |
EPIQ PARTNERS, LLC | 10,463 | $1,055,194 | 0.80% |
Hood River Capital Management LLC | 236,127 | $23,813,408 | 0.76% |
Heritage Wealth Partners, LLC | 3,375 | $340,369 | 0.73% |
Champlain Investment Partners, LLC | 943,260 | $95,127,771 | 0.62% |
WESTWOOD HOLDINGS GROUP INC | 559,157 | $56,391 | 0.53% |